Understanding Blood Transfusion Procedures and Risks

A blood transfusion primarily serves to transfer blood components—such as red blood cells, plasma, or platelets—from a donor to a recipient. This process is crucial for restoring blood volume, improving oxygen delivery, and treating various medical conditions. While it can indirectly increase blood volume and support oxygenation, the fundamental aim is to ensure that the recipient receives the necessary components for effective blood function and overall health.

Blood should be stored at 2 - 6 °C to maintain its viability and prevent bacterial growth. This temperature range slows down metabolic processes and preserves the integrity of red blood cells and other components. Storing blood at temperatures outside this range can lead to degradation and reduced efficacy, making it unsuitable for transfusions. Proper temperature control is critical in blood banks to ensure the safety and quality of blood products for patients in need.

Packed red cells are primarily used to treat anemia because they contain a concentrated amount of red blood cells, which are essential for transporting oxygen throughout the body. Anemia often results from a deficiency in red blood cells, leading to reduced oxygen delivery to tissues. By transfusing packed red cells, healthcare providers can quickly restore the necessary red blood cell count, improving oxygenation and alleviating symptoms associated with anemia. Other blood components, such as plasma or platelets, do not address the specific deficiency of red blood cells in anemia.

Red blood cells can be stored for a maximum of 7 days under optimal conditions. This duration is due to the preservation methods used, which maintain cell viability and functionality. After this period, the quality of the red blood cells declines significantly, leading to reduced effectiveness in oxygen transport and increased risk of adverse reactions during transfusion. Blood banks typically aim to use or transfuse stored red blood cells within this timeframe to ensure patient safety and optimal outcomes.

Blood group O is considered the universal donor because it lacks A and B antigens on the surface of its red blood cells. This means that O type blood can be transfused to individuals of any other blood group without triggering an immune response, as there are no foreign antigens present that could be recognized as threats by the recipient's immune system. This property makes O blood essential in emergency situations where blood type compatibility is not immediately known.

Transfusion of ABO incompatible blood can lead to a hemolytic reaction, where the recipient's immune system identifies the transfused red blood cells as foreign. This triggers an immune response, causing the destruction (hemolysis) of the incompatible cells. Symptoms may include fever, chills, back pain, and dark urine. Severe cases can lead to complications such as acute kidney injury or shock. This reaction underscores the importance of blood type matching before transfusions to ensure patient safety.

An acceptable hemoglobin level of 6 g/dL for patients not undergoing major surgery is based on the threshold for maintaining adequate oxygen delivery to tissues. Levels below this can lead to significant physiological stress and complications, while levels above are generally considered safer. In non-surgical patients, a hemoglobin level of 6 g/dL is often deemed sufficient to prevent anemia-related symptoms and ensure stable health, allowing for effective management without the immediate need for transfusions or interventions typically associated with lower levels.

Massive blood transfusions can lead to hypothermia because stored blood is typically refrigerated and administered at low temperatures. When large volumes of cold blood are rapidly infused into a patient, it can lower the body temperature significantly, impairing physiological functions and increasing the risk of complications. Maintaining normothermia is crucial during such procedures, as hypothermia can exacerbate coagulopathy and affect the overall outcome of the treatment.

Citrate acts as an anticoagulant in blood collection bags by binding to calcium ions in the blood. Calcium is essential for the clotting process, and by sequestering it, citrate effectively inhibits the formation of blood clots. This property is crucial for maintaining the integrity of the blood sample during storage and transport, ensuring that the red blood cells remain viable for transfusion or further testing. Thus, citrate plays a vital role in preserving the quality of collected blood.

A pyrogenic reaction during a transfusion is typically caused by the release of pyrogens, which are substances that induce fever. This reaction often leads to symptoms such as chills and fever, as the body responds to these foreign substances. These symptoms can occur as the immune system reacts to the transfused blood components, resulting in an increase in body temperature and associated chills. Other symptoms like nausea, headache, or itching may occur but are less characteristic of this specific type of reaction.